Skip to content

A comparative study on two parts of Kanchnar and their effectiveness in management of dyslipidemia.

A comparative phytochemical study on root bark and stem bark of Kanchnar and comparision in clinical effectiveness of their churna kalpana in dyslipidemia. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/114085
Enrollment
70
Registered
2026-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

Dr. Neha Rani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 21-60 years and having the level of bad lipids above the upper limit of normal range but below the lower level of the range mentioned as high value by WHO. Patient currently not taking lipid lowering medication such as statin, fibrates, niacin since the last 4 weeks. Patient who has given written informed consent to participate in trial and agreement to abstain from any new supplement or herbal preparation during the study.

Exclusion criteria

Exclusion criteria: If patient is having any grave health problem like liver cirrhosis, Renal insufficiency Cardiovascular events such as MI, stroke cardiac surgery within last 6 months. Pregnant women, lactating women or those planning conception during the study period. If patient is on medications affecting the lipid metabolism like corticosteroids, beta blocker and oral contraceptives.

Design outcomes

Primary

MeasureTime frame
The trial drugs selected for the study viz. churna kalpana of root bark and stem bark of kanchnar is effective in management of dyslipidemia. Any of those two can be more effective.Timepoint: The duration of intervention will be 60 days.Follow up of the patient will be done after 30 days and 60 days after enrollment of patient in study.The assessment of objective criteria that are lab investigations will be done on ist day of study that is before starting of medication, after 30 days of medication and after 60 days of medication.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Naresh Kumar

MSM Institute of Ayurveda, BPSMV, Khanpur Kalan, Sonipat, 131305, Haryana

nareshbhargav73@gmail.com9416051032

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026